Road to a Cure - Dr. Sara Hurvitz
This is the second stop in our Road to A Cure series, with a new interview on the concept of a CURE releasing every Monday until the beginning of the San Antonio Breast Cancer Symposium in early December. Co-hosts Victoria Goldberg and Kate Pfitzer sit down with the Medical Director of the Clinical Researcher Unit of the Jonsson Comprehensive Cancer Center and the Director of the Breast Cancer Clinical Trials Program at UCLA, Dr. Sara Hurvitz.
Dr. Hurvitz has won numerous awards over the past few years, among them the Marni Levine Memorial Breast Cancer Research Award 2008 through 2015. She has an active clinical practice specializing in the treatment of women with breast cancer. She is involved in designing, implementing and leading multiple national and international clinical trials testing new targeted therapies and also leads the preclinical evaluation of novel breast cancer targets in the Translation Oncology Research Laboratory at UCLA.
Join us as we make over 10 stops all over the U.S. (with one stop in Europe) on this Road to a Cure - every Monday until the start of the San Antonio Breast Cancer Symposium in December!
Mentioned in this Episode
HER2+
Clinical Study:
FDA Grants Breakthrough Therapy Designation to Trastuzumab Deruxtecan for HER2+ mBC
Novel HER2-Targeted Therapies Pose Sequencing Challenges
Low HER2
Clinical Trials
ER+
ESMO 2021 - MONALEESA-2: RIBOCICLIB EXTENDS OS ON HR-POSITIVE/HER2-NEGATIVE ADVANCED BREAST CANCER
Clinical Trials
Mentioned in this Series
Sledge (2016) Curing Metastatic Breast Cancer
Susan G. Komen Breast Cancer Statistics
